Preliminary
Genetics & Genomics — Gene therapy, CRISPR, epigenetic clocks, and genomic determinants of aging
Review / Commentary
PubMed
Gene therapy might eventually slow aging in humans, but we're still in early lab stages—decades away from knowing if it actually works.
Gene therapy demonstrates multi-organ anti-aging efficacy in preclinical models via targeting senescence, mitochondrial dysfunction, and immune decline; human translation remains blocked by immunogenicity, off-target risk, and regulatory uncertainty.
This review examines gene therapy's potential to combat aging by targeting fundamental aging processes across multiple organ systems, citing encouraging preclinical results in nervous, muscular, circulatory, and immune systems. However, the authors emphasize that translating …
Ageing research reviews